Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide is a synthetic small molecule belonging to the pyrazole carboxamide class. It has the molecular formula C12H11FN4O2 and a molecular weight of approximately 262.24 g/mol[1][2][6]. The compound is primarily referenced in chemical and pharmacological databases as an experimental or research molecule, with no approved medical indications or marketed formulations[6][8]. Its structure features a pyrazole core substituted with an acetylamino group at position 4 and a carboxamide linked to a para-fluorophenyl ring at position 3. While detailed pharmacological data are limited, it is classified as having potential anti-inflammatory activity and may interact with cyclin-dependent kinase pathways based on its structural class[9]. No clinical trials or therapeutic uses have been reported for this compound.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide.